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cohort of women with obesity
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Abstract.14
INTRODUCTION: Urinary incontinence (UI) is frequently associated with obesity. The prevalence of the different UI types
in women with obesity remains scarcely investigated and controversial.
15
16
OBJECTIVE: The goal of this study was to investigate the prevalence of the different types of UI (stress urinary incontinence,





METHODS: In this observational study, 248 obese female patients (BMI ≥ 30 Kg/m2, age: 62.8 + 10.9 years) admitted to
hospital from April 2019 to September 2019 for a multidisciplinary rehabilitation program were recruited for this study. The
International Consultation on Incontinence Questionnaire - short form (ICIQ-sf) was used to screen the presence of symptoms
of UI and to differentiate the different UI types. Patients with ICIQ-sf score ≥ 4, were asked to undertake the Pad Test for






RESULTS: 61.69% of our sample presented UI symptoms. The prevalence of UI appears to be lower in younger age groups
(57% in 31–46 years of age and 52% in 47–62 years of age) and higher (69%) between 63 and 79 years of age. MUI was the






CONCLUSION: This study demonstrated that UI has a high prevalence in females with obesity and it is not an exclusive
concern of older women. This high prevalence calls for specific rehabilitation interventions within multidisciplinary programs.29
30
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1. Introduction32
The International Continence Society recognises33
three forms of Urinary Incontinence (UI) [1, 2]: a)34
stress urinary incontinence (SUI), when the urinary35
leak is caused by a stimulus like sneeze, physical36
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stress or cough that cause pressure to the bladder; 37
b) urge urinary incontinence (UUI), determined by a 38
sudden and incontrollable contraction of the bladder; 39
c) mixed urinary incontinence (MUI), the combina- 40
tion of the two previous types. 41
A recent internet survey based on a health-related 42
quality of life questionnaire [3] on a sample of 8284 43
subjects over 40 years of age in China, Taiwan and 44
South Korea showed a general prevalence of UI of 45
22% (17,3% in males, 26,4% in females). The most 46
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frequent UI type appears to be MUI (9,7%), followed47
by SUI (7,9%) and UUI (4,3%).48
Women are more prone to UI than men in every49
age range [4, 5]. This is due to a combination of fac-50
tors, including female anatomy, hormonal changes51
and pregnancy, which can cause relaxation of the52
pelvic floor and consequent urinary leaks. [6, 7]. Obe-53
sity is strongly associated with UI, independently54
from other factors [1, 8, 9]: the risk of developing UI55
increases 20% to 70% every 5-unit BMI increase [9].56
A prevalence of 60% has been previously reported57
in women with obesity [10, 11]. From a pathophys-58
iological point of view, increases in intra-abdominal59
pressure secondary to obesity lead to an increase in60
bladder pressure and stress on the pelvic muscles61
thus determining UI [12]. However, there is limited62
conflicting research on the prevalence of the three dif-63
ferent UI types in women with obesity. Three studies64
reported SUI to be more frequent as compared to UUI65
(25% vs 15% [13] and 30% vs 15% [14, 15]). Another66
study reported MUI as the most frequent type [11].67
UI has an impact on social, personal hygiene and68
Quality of life (Qol) aspects [16–18].69
Since both UI and obesity can lead to a reduced70
Qol and high costs for National Health Systems, it is71
therefore important to investigate the relationship of72
these two factors. UI should be diagnosed on the basis73
of laboratory findings, bladder function, imaging tests74
together with clinical examination and bladder diary.75
When the aim is to assess the presence of UI in76
large cohorts of subjects with obesity the whole range77
of tests and evaluations can be unpractical and not78
always feasible to be carried out. For epidemiological79
purposes questionnaires for the detection of UI symp-80
toms have been developed. The goal of the present81
study was therefore to investigate the prevalence of82
the different types of UI (SUI, UUI or MUI) in a large83
sample of female patients with obesity by means of84
a specific questionnaire and non-invasive tests.85
2. Materials and methods86
2.1. Participants87
From April 2019 to September 2019, we consec-88
utively enrolled into this study 248 female patients89
with BMI ≥ 30 Kg/m2 and with an age between 3090
and 79 years, who had been admitted to S Giuseppe91
Hospital, Istituto Auxologico Italiano, for a multidis-92
ciplinary rehabilitation program. Exclusion criteria93
were: anterior prolapse greater than 3rd degree,94
inability to walk for 30 meters, presence of neurolog- 95
ical bladder, psychiatric conditions or dementia that 96
would hamper the use of questionnaires. The study 97
was approved by the Ethical Committee of the Istituto 98
Auxologico Italiano. All procedures performed in the 99
study were in accordance with the ethical standards 100
of the institutional and national research commit- 101
tee and with 1964 Declaration of Helsinki and its 102
later amendments or comparable ethical standards. 103
All participants gave written informed consent after 104
being fully informed about the purpose of the study 105
and the option to withdraw at any time. 106
2.2. Outcome measures 107
The International Consultation on Incontinence 108
Questionnaire - short form (ICIQ-sf) was used to 109
assess the presence of UI symptoms. The ICIQ-sf 110
evaluates frequency, severity and impact of UI on 111
quality of life (Qol). The four parameters investigated 112
were: frequency and quantity of the leaks, global 113
impact of UI and overall patient’s condition [19]. The 114
questionnaire also investigates the different UI types 115
by asking whether leaks occur after coughing or phys- 116
ical activity (SUI), or before managing to get to the 117
toilet on time (UUI), or a combination of the two 118
(MUI). The score ranges from 0 to 21 points, where 119
1–5 = mild UI; 6–12 = moderate UI; 13–18 = severe 120
UI; 19–21 = very severe UI [20]. A total ICIQ-sf score 121
greater than or equal to 4 was considered positive 122
for UI. 123
Patients who resulted positive for SUI or MUI 124
underwent the 1-hour Pad Test, a first-level uro- 125
dynamic test to quantify urinary leaks [21]. This 126
provocative test consists of asking the patient to wear 127
a dry diaper that had been previously weighted, then 128
drink 500 ml of water, and, after 30 min, perform vari- 129
ous physical activities (walk, climb stairs, raise from 130
a sitting position for 10 times, cough for 10 times, 131
run on the spot for a minute, bend down and lift an 132
object from the ground for five times) while wearing 133
the pad. The total duration of the test is one hour. At 134
the end of the test, the diaper is weighted again and 135
if the weight variation is ≥ 1 g the test is considered 136
positive for SUI [16]. 137
The Statistica software (statSoft, USA) was used 138
for statistical analysis. 139
The analysis followed a qualitative description and 140
quantitative presentation of the findings using fre- 141
quency distribution, percentages, and graphs. Then, 142
the mean value and standard deviation of ICIQ-sf 143
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Table 1
Demographic features of the analyzed sample (mean and
standard deviation)
Mean and standard deviation
Age (yrs) 62.8 (10.9)
BMI (Kg/m2) 44.8 (7.1)
ICIQ-sf score 7.4 (6.2)
BMI: Body Mass Index; ICIQ-sf: International Consultation on
Incontinence Questionnaire - short form.
Fig. 1. Patients (number and percentage) with and without symp-
toms of urinary incontinence (UI)
and over 65 years were compared with t-test for inde-145
pendent samples. The Pearson correlation coefficient146
was calculated to examine the relationship between147
ICIQ-sf score and BMI. The level of significance was148
set at p = 0.05, as this is a widely accepted criterion149
for clinically meaningful evidence in research, pro-150
viding a strong evidence against the null hypothesis151
[22].152
3. Results153
The demographic features of the 248 participants154
are described in Table 1. The age range of participants155
was 31–79 years (mean age: 62.8 + 10.9 years). BMI156
ranged from 30.5 Kg/m2 to 72.7 Kg/m2. The num-157
ber of participants with UI (ICIQ-sf score ≥ 4) was158
153/248 (61.7%) (Fig. 1).159
MUI (57.5%) was the most prevalent type of UI,160
followed by UUI (21.6%) and then SUI (20.9%)161
(Fig. 2).162
We reported the mean values of the scores obtained163
in the ICIQ-sf questionnaire of participants aged164
under 65 years and over 65 years (Table 2). From165
the data it is possible to observe that the difference166
between under and over 65 years is statistically dif-167
ferent in terms of ICIQ-sf score (p < 0.05).168
The prevalence of UI was lower in the younger169
patients (prevalence of 57% in the age range 31–46170
Fig. 2. The three different types of UI.
Table 2
Mean (standard deviation) of ICIQ-sf score for patients under
and over 65 years. ∗ = p < 0.05, under 65 years vs. over 65 years
Under 65 years Over 65 years
Numerosity (#) 138 110
ICIQ-sf score 5.9 (5.6) 9.4 (6.4)∗
ICIQ-sf: International Consultation on Incontinence Questionnaire
- short form.
Fig. 3. Different types of UI in different age ranges.
years, and 52% in the age range 47–62 years) as com- 171
pared to older patients (prevalence of 69% in the age 172
range 63–79 years). 173
SUI was the most prevalent type of UI (50%) 174
in younger participants (31–46-year-old), followed 175
by MUI (33%) and UUI (17%). In the other two 176
age ranges (47–62 and 63–79-year-old patients) the 177
prevalence of SUI decreased, while MUI and UUI 178
increased parallel to age: in 47–62-year-old patients 179
SUI was 26%, MUI 54%, UUI 20%; in 63–79-year- 180
old patients SUI was 14%, MUI 62%, UUI 24% 181
(Fig. 3). 182
In our study, no correlation was found between 183
different BMI and the severity of incontinence (ICIQ- 184
sf scores) (p > 0.05). 185
Out of 153 patients with UI symptoms (ICIQ-sf 186
score ≥ 4), 120 who presented stress incontinence 187
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Pad Test; 55% of participants presented with urine189
leaks ≥ 1 g, evidencing the presence of SUI.190
4. Discussion191
In subjects with obesity an increase in the load-192
ing on the pelvic muscles and on the bladder has193
been reported [23]. A 60% prevalence of UI has been194
reported in the literature. Our general prevalence data195
(61.69%) are in line with the current literature. None196
of our experimental subjects withdrew from the study.197
UI appears to be relatively less prevalent in younger198
age groups, whereas the prevalence rises to 69% in199
the age range between 63 and 79 years. According200
to our findings, the most frequent type of UI in our201
experimental sample with obesity was MUI (57.5%),202
followed by the SUI (21.5%) and UUI (20.9%).203
MUI typically appears after menopause and can204
be attributed to the decrease of blood estrogens level205
after menopause, causing urogenital atrophy and206
development of lower urinary tract infections facil-207
itating urinary leaks, a hyperactivity of the detrusor208
muscle of the bladder and alteration of the tissue209
trophism [24]. Our findings of a UI prevalence of210
57% in 31–46 years old and of 52% in 47–62 years211
old women suggest that UI does not appear a problem212
exclusive of elderly women.213
The novelty of our study was to describe the preva-214
lence of the three UI types across different ages. As215
for which UI type was more prevalent in different216
age ranges, SUI was reported in 50% of the younger217
(31–46-year-old) patients, followed by MUI (33%)218
and UUI (17%). The excess of body mass induces219
an increase in intra-abdominal pressure with conse-220
quent overload of ligaments and muscles of the pelvic221
floor, ultimately determining SUI in younger patients.222
In the other two age ranges (47–62 and 63–79-year-223
old patients), the prevalence of SUI decreased, while224
MUI and UUI increased parallel to age. In the older225
patients, factors related to hormonal changes due to226
menopause may account for the onset of UUI (i.e.,227
hyperactivity of the detrusor muscle), which eventu-228
ally may evolve into MUI.229
UI-related reduction in Qol and discomfort in230
daily and sexual life may therefore occur also in231
younger patients with obesity [25, 26]. UI may also232
worsen depression and anxiety that are frequent233
obesity-related features, thus negatively impacting234
the patients’ social and productive life [27, 28].235
The questionnaire we used in this study, the ICIQ-236
SF, was developed for a clinical use on all patients237
with UI regardless of gender and age and for compar- 238
ing studies on UI. It is a brief and psychometrically 239
robust patient-completed questionnaire for evaluat- 240
ing frequency, severity and impact on Qol of UI in 241
research and clinical practice across the world. It 242
includes 3 questions related to the frequency of UI, 243
the ordinary amount of UI, and its influence on daily 244
life. The scores of the 3 questions were summed 245
and the resulting totals ranged between 0 and 21 246
points.. The validity, reliability, and responsiveness 247
of the ICIQ-SF for UI had been previously verified 248
[19]. 249
Out of 153 patients with UI symptoms (ICIQ-sf 250
score ≥ 4) on a total sample of 248, 120 who pre- 251
sented stress incontinence symptoms (SUI or MUI) 252
undertook the 1-Hour Pad Test. Only 55% of the 253
patients presenting stress incontinence symptoms 254
were positive at the 1-Hour Pad Test with urine 255
leaks ≥ 1 g. Several factors may have accounted for 256
the discrepancy between subjective perception of the 257
symptoms, as assessed by the questionnaire, and the 258
quantification of urine leaks, as assessed by the 1- 259
Hour Pad Test. Individual emotional and behavioral 260
factors, different levels of physical activity and differ- 261
ent bladder filling durations among the experimental 262
subjects, which were not investigated in this study, 263
may have indeed affected the results. Since individual 264
habitual levels of physical capacity were not known, 265
the stresses imposed during the 1-Hour Pad Test may 266
have not been sufficient for all the patients to pro- 267
voke urinary leaks. The test is non-invasive and easy 268
to perform, yet factors such as embarrassment and 269
behavioral changes to reduce incontinence severity 270
(inactivity, fluid restriction) could significantly affect 271
the outcome. Also, variability in how the test has 272
been performed in different studies makes compar- 273
ison of published results difficult. Different testing 274
durations have been reported in the literature, but only 275
for the 1-hour Pad Test a specific test protocol has 276
been standardized [29, 30]. A number of studies have 277
documented that the longer the testing, the better the 278
correlation between the test results and the degree 279
of incontinence. However, 24- to 72-hr Pad Tests 280
are cumbersome and require high levels of patient 281
compliance [31]. For such reasons, we used the 1- 282
hour Pad Test. We are aware that negative 1-hour 283
Pad Test should be cautiously interpreted. Unfor- 284
tunately, organizational constraints did not allow 285
repeated short-term testing in cases where test result 286
did not correlate with subjective assessment provided 287
by the patient. This could also have accounted for the 288
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of incontinence symptoms (questionnaire) and their290
objective measurement (Pad Test).291
Our study presents with other limitations. Our292
patients did not have a clinical and instrumental uro-293
dynamic diagnosis. The ICIQ-sf questionnaire used294
in this study does not define cut-off values to establish295
whether or not a patient presents UI symptoms. For296
this reason, we opted for a cut-off value of 4 points,297
which represents the minimum score associated with298
UI symptoms.299
Another limitation was that the presence of resid-300
ual urine in the bladder was not investigated and,301
consequently, urinary retention was not considered302
as a possible cause of UI. However, urinary retention303
is usually secondary to neurological disorders caus-304
ing dyssynergia and premature closure of the urethral305
sphincter, which were among the exclusion criteria of306
the study.307
In conclusion, data emerging from this observa-308
tional study about the association between obesity309
and UI are in line with the literature. The experimen-310
tal sample of female patients with obesity in our study311
shows a wide age range and appears representative of312
a general population with obesity. The high preva-313
lence of UI calls for specific interventions within314
multidisciplinary rehabilitation programs. UI is not315
only a feature of older age, it also affects younger316
women with obesity and their Qol. Further research317
is needed to investigate whether rehabilitation inter-318
ventions for the pelvic floor are effective in the obese319
population and can be age- and symptom-specific.320
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